DNLI
Denali Therapeutics Inc.
$13.37
+$0.62(+4.82%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$1.86B
Volume
1.63M
52W Range
$10.57 - $33.33
Target Price
$32.20
EPS Estimates Overview
| Current Quarter | $-0.76 | Next Quarter | $-0.77 |
| Current Year | $-3.04 | Next Year | $-2.93 |
| QoQ Growth | -1.3% | YoY Growth | +3.6% |
| 3Y EPS CAGR | -2.5% | Target Price | $32.20 |
| Consensus | Buy | Upside | +140.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $13.37 | +4.8% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW